Please do your own dd...
Neuren Pharma ( NEU.AX)
Marketcap: only 36 million A$
Price: 0,25 A$
Awesome Pipeline :
Glypromate MCI in CABG Phase 3 ongoing
NNZ-2566 Severe TBI (traumatic brain injury) Phase 2a (deal with US Army)
NNZ-2566 Mild/Mod TBI Phase 2
Motiva Post-stroke-Apathy Phase 2b
Clinical development update 4 Dec 2007:
http://www.neurenpharma.com/images/NEU%20Clinical%20Trials%20Update%20Dec%202007.pdf
Presentation 3 Dec 2007:
http://www.neurenpharma.com/images/Neuren%20AU%20Presentation%20Dec%202007.pdf
New Homepage:
http://www.neurenpharma.com/
Taylor Collison
http://preset.sphilo.com/neuren/images/NEU%200708%20-%20Hamilton.pdf
By the end 1Q CY08, we expect Neuren to be running four major
efficacy trials; namely three Phase 2 trials for NNZ-2566 in
mild/moderate and severe TBI and Motiva� in post stroke abulia/
depression coupled with the current Phase 3 trial for Glypromate� in
CABG. All indications potentially provide Neuren with first to market,
billion dollar opportunities. With a current market cap of $40.2m, Neuren
remains a solid value proposition in the sector, where FDA INDs for mid
to late stage clinical trials continues to remain a vexing proposition. We
maintain our Speculative Buy recommendation and price target of $1.30,
though expect to make changes to our valuation model once the
acquisition has closed, which we expect during the current Q.
- Forums
- ASX - General
- ASX
- best biotech in australia youve never heard of
best biotech in australia youve never heard of
Featured News
Add ASX (ASX) to my watchlist
|
|||||
Last
$62.36 |
Change
0.710(1.15%) |
Mkt cap ! $12.09B |
Open | High | Low | Value | Volume |
$61.50 | $62.46 | $61.13 | $19.55M | 314.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13 | $62.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$62.36 | 7749 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13 | 62.340 |
2 | 15 | 62.320 |
1 | 160 | 62.300 |
1 | 359 | 62.270 |
1 | 6 | 62.240 |
Price($) | Vol. | No. |
---|---|---|
62.360 | 7749 | 1 |
62.470 | 976 | 2 |
62.500 | 1038 | 3 |
62.530 | 45 | 1 |
62.580 | 1087 | 1 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
ASX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online